|
|
 |
|
 |
July 29, 2005
MDX Medical Arranges Sale of Shares
Vancouver, BC, July 29, 2005 - MDX Medical Inc. (TSX.V: MDX) Further to the company's News Release issued July 27, 2005, MDX Medical reports that certain directors of the company have arranged a sale of 3,400,500 shares at a price of $0.075 per share through the facilities of the TSX Venture Exchange, July 29, 2005. The proceeds from this sale will be used to fund the Private Placement of 3,400,500 Units of MDX at a price of $0.075.
About MDX Medical
MDX Medical Inc.'s focus is on commercializing novel, innovative and leading edge medical device technologies for improved diagnosis and treatment of cancer and other prominent health disorders. The Company's business strategy is to acquire promising technologies that have reached the "proof of feasibility" or later stages of product development, complete the final stages of commercialization, obtain the required regulatory approvals and pursue strategic marketing partners. For more information about MDX, please visit our website at: www.mdxmedical.com.
On behalf of the Board,
"Barry Allen"
President & CEO
MDX Medical Inc.
Certain information contained in this press release may be forward looking and is subject to unknown risks, which could cause actual results to differ materially from those, set forth or implied herein. Although the Company believes that the expectations reflected in such forward looking statements are reasonable, it can give no assurance that such expectations will prove correct.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Larry Horsburgh
Phone: (604) 694-7770, Ext. 112
Email: lhorsburgh@mdxmedical.com |
|  |
|
